Xiang-Dong Cheng (Can Hu)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Topics

Locally Advanced

Epidermal Growth Factor Receptor

Neoadjuvant Chemotherapy

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer management and research

Journal of oncology

International journal of surgery (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Qing Wei, Teng Yang, Jiayu Zhu, Ziwen Zhang, Le Yang, Yuchao Zhang, Xiang-Dong Cheng, Jiahui Chen, Jinchao Wang, Xuefei Tian, Takaya Shimura, Jianmin Fang, Jie-Er Ying, Mengyang Fan, Peng Guo, Xiangdong Cheng
Spatiotemporal Quantification of HER2-targeting Antibody-Drug Conjugate Bystander Activity and Enhancement of Solid Tumor Penetration. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (5) (2024)
Qing Wei, Teng Yang, Jiayu Zhu, Ziwen Zhang, Le Yang, Yuchao Zhang, Xiang-Dong Cheng, Jiahui Chen, Jinchao Wang, Xuefei Tian, Takaya Shimura, Jianmin Fang, Jie-Er Ying, Mengyang Fan, Peng Guo, Xiangdong Cheng
Spatiotemporal Quantification of HER2-targeting Antibody-Drug Conjugate Bystander Activity and Enhancement of Solid Tumor Penetration. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (5) (2024)
Yuqi Wang, Jingli Xu, Zhenjie Fu, Ruolan Zhang, Weiwei Zhu, Qianyu Zhao, Ping Wang, Xiang-Dong Cheng, Xiangdong Cheng
The role of reactive oxygen species in gastric cancer. Cancer biology & medicine (2024)
Qing Wei, Teng Yang, Jiayu Zhu, Ziwen Zhang, Le Yang, Yuchao Zhang, Xiang-Dong Cheng, Jiahui Chen, Jinchao Wang, Xuefei Tian, Takaya Shimura, Jianmin Fang, Jie-Er Ying, Mengyang Fan, Peng Guo, Xiangdong Cheng
Spatiotemporal quantification of HER2-targeting antibody-drug conjugate bystander activity and enhancement of solid tumor penetration. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Xiang-Dong Cheng, Jiahui Chen, Feng Li, Yanqiang Zhang, Pengfei Yu, Litao Yang, Ling Huang, Jiancheng Sun, Shangqi Chen, Chengwei Shi, Yuanshui Sun, Zaisheng Ye, Li Yuan, Jiahui Chen, Qin Wei, Jingli Xu, Handong Xu, Yahan Tong, Zhehan Bao, Chencui Huang, Yiming Li, Yian Du, Zhiyuan Xu, Xiangdong Cheng
Deep learning radio-clinical signature for predicting neoadjuvant chemotherapy response and prognosis from pretreatment CT images of locally advanced gastric cancer patients. International journal of surgery (London, England) (2023)
Pengcheng Yu, Weiyang He, Yanqiang Zhang, Xiang-Dong Cheng, Yue Wu, Yi Wang, Zhehan Bao, Yuhang Xia, Ruolan Zhang, Mengxuan Cao, Li Yuan, Xiang-Dong Cheng, Zhiyuan Xu
SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer. Journal of oncology 2022 (2022)
Zhehan Bao, Yanqiang Zhang, Pengcheng Yu, Yi Wang, Xiang-Dong Cheng, Yuhang Xia, Li Yuan, Zhi-Yuan Xu, Xiang-Dong Cheng
High CHAF1A Expression Levels Are Positively-Correlated with PD-L1 Expression and Indicate Poor Prognosis in Gastric Cancer. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Zhi-Yuan Xu, Can Hu, Shangqi Chen, Yi-An Du, Ling Huang, Peng-Fei Yu, Li-Jing Wang, Xiang-Dong Cheng
Evaluation of D2-plus radical resection for gastric cancer with pyloric invasion. BMC surgery 19 (1) (2019)
Zhiyuan Xu, Xiang-Dong Cheng, Shangqi Chen, Chunli Zhang, Jianfa Yu, Xiaofeng Wang, Hang Lv, Xiang-Dong Cheng
Apatinib enhances chemosensitivity of gastric cancer to paclitaxel and 5-fluorouracil. Cancer management and research 11 (2019)